Page last updated: 2024-09-05

sch 58261 and kf 17837

sch 58261 has been researched along with kf 17837 in 2 studies

Compound Research Comparison

Studies (sch 58261)	Trials (sch 58261)	Recent Studies (post-2010) (sch 58261)	Studies (kf 17837)	Trials (kf 17837)	Recent Studies (post-2010) (kf 17837)
46	0	14	8	0	0

Protein Interaction Comparison

Protein	Taxonomy	kf 17837 (IC50)
Adenosine receptor A1	Rattus norvegicus (Norway rat)	0.062
Adenosine receptor A2a	Homo sapiens (human)	0.001
Adenosine receptor A2b	Homo sapiens (human)	1.5

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, L; Engber, T; Grant, D; Hetu, G; Huang, C; Jin, X; Kumaravel, G; Peng, B; Petter, RC; Phadke, D; Reilly, J; Smits, G; Tam, S; Vu, CB; Zhang, J	1
Engber, T; Grant, D; Hetu, G; Huang, C; Jin, X; Kumaravel, G; Pan, D; Peng, B; Petter, RC; Phadke, D; Reilly, J; Smits, G; Tam, S; Vu, CB	1

Other Studies

2 other study(ies) available for sch 58261 and kf 17837

Article	Year
Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17 Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Biological Availability; Brain; Catalepsy; Heterocyclic Compounds, 2-Ring; In Vitro Techniques; Male; Mice; Parkinsonian Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Structure-Activity Relationship; Triazines; Triazoles	2004
Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6 Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Binding, Competitive; Biological Availability; Catalepsy; Cerebral Cortex; Combinatorial Chemistry Techniques; Diamines; In Vitro Techniques; Male; Mice; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereoisomerism; Triazines; Triazoles	2005

Article

Year

Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.

Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Biological Availability; Brain; Catalepsy; Heterocyclic Compounds, 2-Ring; In Vitro Techniques; Male; Mice; Parkinsonian Disorders; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Structure-Activity Relationship; Triazines; Triazoles

2004

Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.

Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

Topics: Adenosine A2 Receptor Antagonists; Administration, Oral; Animals; Antiparkinson Agents; Binding, Competitive; Biological Availability; Catalepsy; Cerebral Cortex; Combinatorial Chemistry Techniques; Diamines; In Vitro Techniques; Male; Mice; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereoisomerism; Triazines; Triazoles

2005